Advisory Board

GBX Summits works in conjunction with some of the world’s foremost leaders and visionaries in a variety of key industries to produce cutting-edge programs that stimulate, educate and accelerate innovation.

The Steering Committee and Speaker Faculty at a Glance

Dr. Rod MacKenzie
Senior Vice President and Head of Global Research
Pfizer Inc

Dr. Rod MacKenzie, Ph.D. serves as Senior Vice President and Global Research Director for Pharmacotherapeutic Research and Development at Pfizer Inc. and has been their Groton Site Leader since April 25, 2012, and has been President of research and development of pharmacotherapeutics since May 2010…

Steve Street joined Pfizer in 1985 and held various positions in the Chemistry Department in Sandwich, UK, before being appointed Head of Chemistry at Sandwich Discovery in 2001. Three years later, in early 2004, Steve moved to establish and direct Chemistry. He disciplines the entire world of discovery.

As Chief Scientific Officer and Executive Vice President of Global Laboratory Services, Lee Babies, Ph.D., provides strategic direction and scientific expertise to PPD’s Global Core, cGMP, and Bioanalytical Laboratories, PPD’s Center of Excellence for Vaccines and Biologics, and BioDuro, your Beijing drug discovery services company.

Babies brings to PPD more than 21 years of experience in the development and leadership of research and development laboratories. Most recently he served as President and Director of Pharmaceutical Research at F. Hoffmann-La Roche, Ltd., in Basel, Switzerland, where his responsibilities included creating global laboratory functions in chemistry, discovery technologies, therapeutic proteins. , non-clinical and IT security.

He supported drug discovery efforts in oncology, neuroscience, inflammation, virology, and metabolism and served on the company’s executive and strategic portfolio committees.

Before joining Hoffmann-La Roche, Babies spent seven years at Glaxo Inc., now GlaxoSmithKline. As vice president of life sciences and genetics, he had global responsibility for developing and implementing the company’s corporate genetics strategy and cell cycle-focused oncology research efforts.

Babiss earned a doctorate in microbiology from Columbia University and completed his postdoctoral fellowship at Rockefeller University, where he served as an assistant and associate professor. He has received numerous awards and fellowship grants and is a member of various scientific advisory boards and committees.

Thomas has a Ph.D. in chemical engineering from the University of Stuttgart in Germany. He joined Bayer in Leverkusen in 1991, spent 5 years in the Central Technology Department, and went on to become production leader of the Polyester unit in Dormagen, Germany.

In 1999 he obtained an assignment at CESRO’s Baytown, TX office and in 2002 became Head of the Process Technology Group at Bayer Technology Services in the United States. Since 2007 he directs the BTS Products Group of Applied Sciences and Biotechnology. Consolidating and streamlining the efforts of BTS-Healthcare activities, he moved in 2009 to Bayer’s biotech production location in Berkeley California, and became V.P. from BTS-A Process Technology Healthcare.

Nigel Titchener-Hooker leads the Bioprocessing program at UCL’s Innovative Manufacturing Research Center (IMRC). It is a multidisciplinary group of more than a dozen departments to investigate new methods to accelerate the development of efficient and robust processes for the manufacture of the next generations of macromolecular drugs.

The work brings together researchers from Structural and Molecular Biology (Professor John Ward), and within the Faculty of Engineering Sciences, there are significant collaborations with Computer Sciences (Professor Tony Hunter), Chemical Engineering (Dra. Eva Sorenson and Dr. Lazaros Papageorgiou). Internally, Dr. Dan Bracewell, Dr. Nicolas Szita, Dr. Yuhong Zhou, Dr. Eli Keshavarz-Moore, and Professor Mike Hoare assist Nigel in managing the IMRC consortium comprising 15 leading national and international companies.

Keith Russell obtained his PhD from the University of Cambridge, UK with Dr A. B. Holmes in 1984 in the area of ​​synthetic organic chemistry.